GLP-1 patches for weight loss have made the scene—but a leading MD warns you they aren't the same as the more familiar ...

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.

GLP-1 RAs are not linked to an increased risk for serious GI or hepatobiliary outcomes, compared with other diabetes medications.

Adults with pulmonary arterial hypertension using vs. not using GLP-1 receptor agonists had significantly lower relative ...

In 2025, the average annual premium for family health coverage reached $26,993, an increase of $1,408 (6 percent) from the previous year. Covered workers contributed an average of 16 percent ($1,440) ...

Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?

Eight funds passed the screen, and these five stocks were the non-tech or tech-adjacent names with the largest cumulative ...

A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against ...

Because GLP-1 agonists seem to reduce patients’ desire for food, it isn’t surprising that they might also shrink or even ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study ...

Pharmaceutical company Novo Nordisk is working on an Ozempic-style semaglutide tablet just for weight loss, and early results ...

High School Musical' alum Ashley Tisdale said she doesn't judge people who take Ozempic, but it's not the right choice for ...